Poland· PL-100129127
Trasylol
A aprotinin product containing aprotininum, registered in Poland by Nordic Group B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Aprotinin is registered in 11 of 19 countries.
Countries holding a registration under ATC B02AB01 (aprotinin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Aprotinin · ATC B02AB01
11 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Aprotininum
- Manufacturer
- Nordic Group B.V.
- Country
- Poland (PL)
- ATC code
- B02AB01
- ATC class
- Aprotinin
- Defined daily dose
- 500 TSD, E
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991096519
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for aprotinin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aprotinin · interactions on record
6 records
- 3 severe
- 3 moderate
Most severe, free to view
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
- TretinoinL01XF01severe
- TretinoinL01XX14severe
- AlteplaseB01AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aprotinin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAprotinin 15,000 Kallikrein inactivator units/5ml irrigation solution vialsBaxter Healthcare Ltd
- BelgiumTisseel S/DBaxter
- GermanyTrasylolNordic Group B.V.
- FinlandTrasylolNordic Group B.V.
- FranceTRASYLOL 500 000 UIK/50 mL, solution injectableNORDIC GROUP (PAYS-BAS)
- SwitzerlandTrasylol, Injektions-/InfusionslösungNordic Pharma GmbH
- IrelandTrasylol 10,000 KIU/ml, solution for injection or infusionNordic Group B.V.
- NetherlandsTrasylol, oplossing voor infusie 10.000 KIE/mlNordic Group B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Trasylol
- Belgium · Trasylol
- Germany · Trasylol
- Denmark · Trasylol
- Finland · Trasylol
- France · Trasylol
- United Kingdom (Northern Ireland) · Aprotinin
- Hungary · Gordox
- Ireland · Trasylol
- Luxembourg · Trasylol
- Netherlands · Trasylol
- Portugal · Trasylol
- Sweden · Trasylol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71efa268-06f7-4146-9193-785cd69e12ce GET /v1/drugs/71efa268-06f7-4146-9193-785cd69e12ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "277,8 j. Ph. Eur. (500 000 KIU)",
"packaging": "05909991096519 ¦ Lz ¦ 47951\n1 butelka 50 ml",
"substance": "Aprotininum 10 g",
"common_name": "Aprotininum",
"pl_product_id": "100129127",
"pozwolenie_nr": "10965",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about aprotinin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.